ClinicalTrials.Veeva

Menu

Healing Abutment Materials on Matrix Metalloproteinase-8 Level in Peri-implant Crevicular Fluid

A

Alexandria University

Status

Completed

Conditions

Dental Implants

Treatments

Other: Stock healing abutments
Other: Compoiste healing abutments

Study type

Interventional

Funder types

Other

Identifiers

NCT06034132
Implants_2022_MP8

Details and patient eligibility

About

Numerous materials are nowadays used in the fabrication of healing abutments to be used for dental implants. soft tissue response to different healing abutment materials is still to be unraveled. the Aim of this study is to compare the soft tissue response to titanium stock healing abutments to customized composite healing abutments through assessing the level of matrix metalloproteinase-8 in the peri-implant crevicular fluid

Enrollment

30 patients

Sex

All

Ages

25 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with no systemic and/or oral health disease
  • absence of any lesions in the oral cavity
  • wide band of keratinized tissue more than 1mm at implant site

Exclusion criteria

  • smoking more than 20 cigarettes per day
  • localized radiation therapy of the oral cavity,
  • antitumor chemotherapy, liver diseases, blood diseases, kidney diseases, immunosuppressed patients, patients taking corticosteroids, pregnancy, inflammatory and autoimmune diseases of the oral cavity

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Test group
Experimental group
Treatment:
Other: Compoiste healing abutments
Control group
Active Comparator group
Treatment:
Other: Stock healing abutments

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems